metformin has been researched along with Substance Withdrawal Syndrome in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cigarette smoking is the leading cause of preventable disease and death in the United States, with more persons dying from nicotine addiction than any other preventable cause of death." | 3.88 | Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal. ( Blendy, JA; Brynildsen, JK; Jin, S; Kim, SF; Lee, BG; Perron, IJ, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, J | 1 |
| Zhang, Z | 1 |
| Xie, Z | 1 |
| Bai, L | 1 |
| Xiong, P | 1 |
| Chen, F | 1 |
| Zhu, T | 1 |
| Peng, Q | 1 |
| Wu, H | 1 |
| Zhou, Y | 1 |
| Ma, Y | 1 |
| Zhang, Y | 1 |
| Chen, M | 1 |
| Gao, J | 1 |
| Tian, W | 1 |
| Shi, K | 1 |
| Du, Y | 1 |
| Duan, Y | 1 |
| Wang, H | 1 |
| Xu, Y | 1 |
| Kuang, YQ | 1 |
| Zhu, M | 1 |
| Yu, J | 1 |
| Wang, K | 1 |
| Brynildsen, JK | 1 |
| Lee, BG | 1 |
| Perron, IJ | 1 |
| Jin, S | 1 |
| Kim, SF | 1 |
| Blendy, JA | 1 |
1 trial available for metformin and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program.
Topics: Blood Glucose; Diabetes Mellitus; Fasting; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Metf | 2003 |
2 other studies available for metformin and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Metformin modulates microbiota-derived inosine and ameliorates methamphetamine-induced anxiety and depression-like withdrawal symptoms in mice.
Topics: Amphetamine-Related Disorders; Animals; Anxiety; Depression; Inosine; Metformin; Methamphetamine; Mi | 2022 |
Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anxiety Disorders; Drug Evaluati | 2018 |